| __timestamp | Arrowhead Pharmaceuticals, Inc. | Genmab A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 850385000 |
| Thursday, January 1, 2015 | 382000 | 1133041000 |
| Friday, January 1, 2016 | 158333 | 1816122000 |
| Sunday, January 1, 2017 | 31407709 | 2365436000 |
| Monday, January 1, 2018 | 16142321 | 3025137000 |
| Tuesday, January 1, 2019 | 168795577 | 5366000000 |
| Wednesday, January 1, 2020 | 87992066 | 10111000000 |
| Friday, January 1, 2021 | 138287000 | 8482000000 |
| Saturday, January 1, 2022 | 232810000 | 14595000000 |
| Sunday, January 1, 2023 | 240735000 | 16248000000 |
| Monday, January 1, 2024 | 3551000 | 20541000000 |
Unlocking the unknown
In the competitive landscape of biotechnology, understanding financial health is crucial. This chart offers a decade-long glimpse into the gross profit trajectories of Genmab A/S and Arrowhead Pharmaceuticals, Inc., two prominent players in the industry. From 2014 to 2023, Genmab A/S consistently outperformed Arrowhead, with its gross profit peaking at approximately $16.2 billion in 2023, a staggering 1,900% increase from 2014. In contrast, Arrowhead Pharmaceuticals showed a more modest growth, reaching around $240 million in 2023, marking a significant rise from its 2014 figure of $175,000. This comparison highlights Genmab's robust financial growth and market dominance, while Arrowhead's steady climb reflects its potential in the biotech sector. Notably, data for 2024 is incomplete, indicating a need for cautious interpretation of future trends.
Gross Profit Comparison: Merck & Co., Inc. and Genmab A/S Trends
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs Genmab A/S
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Arrowhead Pharmaceuticals, Inc.
Key Insights on Gross Profit: Biogen Inc. vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs Arrowhead Pharmaceuticals, Inc.
Key Insights on Gross Profit: Genmab A/S vs Jazz Pharmaceuticals plc
Who Generates Higher Gross Profit? Genmab A/S or Travere Therapeutics, Inc.
Gross Profit Analysis: Comparing Incyte Corporation and Arrowhead Pharmaceuticals, Inc.
Gross Profit Trends Compared: Halozyme Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.
Veracyte, Inc. vs Arrowhead Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Arrowhead Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and MiMedx Group, Inc.